157 related articles for article (PubMed ID: 11281363)
1. 11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine.
Diederich S; Quinkler M; Burkhardt P; Grossmann C; Bähr V; Oelkers W
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():21-7. PubMed ID: 11281363
[TBL] [Abstract][Full Text] [Related]
2. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
3. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
Seckl JR
Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.
Sandeep TC; Walker BR
Trends Endocrinol Metab; 2001 Dec; 12(10):446-53. PubMed ID: 11701343
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes.
Holmes MC; Kotelevtsev Y; Mullins JJ; Seckl JR
Mol Cell Endocrinol; 2001 Jan; 171(1-2):15-20. PubMed ID: 11165006
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues.
Quinkler M; Oelkers W; Diederich S
Eur J Endocrinol; 2001 Feb; 144(2):87-97. PubMed ID: 11182744
[TBL] [Abstract][Full Text] [Related]
7. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system.
Seckl JR; Chapman KE
Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341
[TBL] [Abstract][Full Text] [Related]
8. Enzymology and molecular biology of glucocorticoid metabolism in humans.
Blum A; Maser E
Prog Nucleic Acid Res Mol Biol; 2003; 75():173-216. PubMed ID: 14604013
[TBL] [Abstract][Full Text] [Related]
9. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.
Bland R; Worker CA; Noble BS; Eyre LJ; Bujalska IJ; Sheppard MC; Stewart PM; Hewison M
J Endocrinol; 1999 Jun; 161(3):455-64. PubMed ID: 10333548
[TBL] [Abstract][Full Text] [Related]
11. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
13. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
14. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
Maser E; Bannenberg G
Biochem Pharmacol; 1994 May; 47(10):1805-12. PubMed ID: 8204097
[TBL] [Abstract][Full Text] [Related]
15. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action.
Burton PJ; Waddell BJ
Biol Reprod; 1999 Feb; 60(2):234-40. PubMed ID: 9915986
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action.
Waddell BJ; Benediktsson R; Brown RW; Seckl JR
Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929
[TBL] [Abstract][Full Text] [Related]
17. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I.
Diederich S; Grossmann C; Hanke B; Quinkler M; Herrmann M; Bähr V; Oelkers W
Eur J Endocrinol; 2000 Feb; 142(2):200-7. PubMed ID: 10664531
[TBL] [Abstract][Full Text] [Related]
18. Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms.
Oppermann UC; Persson B; Jörnvall H
Eur J Biochem; 1997 Oct; 249(2):355-60. PubMed ID: 9370340
[TBL] [Abstract][Full Text] [Related]
19. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.
Seckl JR; Walker BR
Endocrinology; 2001 Apr; 142(4):1371-6. PubMed ID: 11250914
[TBL] [Abstract][Full Text] [Related]
20. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
Maser E; Friebertshäuser J; Völker B
Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
